Reference | 1: Nagpal N, Wang J, Zeng J, Lo E, Moon DH, Luk K, Braun RO, Burroughs LM, Keel
SB, Reilly C, Lindsley RC, Wolfe SA, Tai AK, Cahan P, Bauer DE, Fong YW, Agarwal
S. Small-Molecule PAPD5 Inhibitors Restore Telomerase Activity in Patient Stem
Cells. Cell Stem Cell. 2020 Apr 17. pii: S1934-5909(20)30138-7. doi:
10.1016/j.stem.2020.03.016. [Epub ahead of print] PubMed PMID: 32320679.
<br>
2: Hyrina A, Jones C, Chen D, Clarkson S, Cochran N, Feucht P, Hoffman G,
Lindeman A, Russ C, Sigoillot F, Tsang T, Uehara K, Xie L, Ganem D, Holdorf M. A
Genome-wide CRISPR Screen Identifies ZCCHC14 as a Host Factor Required for
Hepatitis B Surface Antigen Production. Cell Rep. 2019 Dec 3;29(10):2970-2978.e6.
doi: 10.1016/j.celrep.2019.10.113. PubMed PMID: 31801065.
<br>
3: Mueller H, Lopez A, Tropberger P, Wildum S, Schmaler J, Pedersen L, Han X,
Wang Y, Ottosen S, Yang S, Young JAT, Javanbakht H. PAPD5/7 Are Host Factors That
Are Required for Hepatitis B Virus RNA Stabilization. Hepatology. 2019
Apr;69(4):1398-1411. doi: 10.1002/hep.30329. Epub 2019 Mar 1. PubMed PMID:
30365161.
<br>
4: Han X, Zhou C, Jiang M, Wang Y, Wang J, Cheng Z, Wang M, Liu Y, Liang C, Wang
J, Wang Z, Weikert R, Lv W, Xie J, Yu X, Zhou X, Luangsay S, Shen HC, Mayweg AV,
Javanbakht H, Yang S. Discovery of RG7834: The First-in-Class Selective and
Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel
Mechanism of Action. J Med Chem. 2018 Dec 13;61(23):10619-10634. doi:
10.1021/acs.jmedchem.8b01245. Epub 2018 Oct 17. PubMed PMID: 30286292.
<br>
5: Mueller H, Wildum S, Luangsay S, Walther J, Lopez A, Tropberger P, Ottaviani
G, Lu W, Parrott NJ, Zhang JD, Schmucki R, Racek T, Hoflack JC, Kueng E, Point F,
Zhou X, Steiner G, Lütgehetmann M, Rapp G, Volz T, Dandri M, Yang S, Young JAT,
Javanbakht H. A novel orally available small molecule that inhibits hepatitis B
virus expression. J Hepatol. 2018 Mar;68(3):412-420. doi:
10.1016/j.jhep.2017.10.014. Epub 2017 Oct 25. PubMed PMID: 29079285.
|